Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07434635 · ClinicalTrials.gov registry record · Phase 4
APPRAISE: Assessment of Pain and Posterior Synechiae Reduction With Atropine, an Investigation of Post-Surgical Eyes
A Phase 4 study of Eye Disorders, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 62
- Enrollment target
- 1
- Study location
NCT07434635: Recruiting Phase 4 study of Eye Disorders, sponsored by University of California, San Francisco.
NCT07434635 is a Phase 4 study of Eye Disorders that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 62 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07434635, a Phase 4 study of Eye Disorders, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 62 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will evaluate whether atropine eyedrops are beneficial when used after certain eye surgeries.
Conditions Studied
Interventions
- DRUG Atropine 1%
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2026-02 |
| Est. Completion | 2029-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07434635
The ClinicalTrials.gov registry entry for NCT07434635 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Eye Disorders appearing as the primary indexed condition, and to 1 intervention - of which Atropine 1% is the first listed.
NCT07434635 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07434635 about?
NCT07434635 is a clinical study titled "APPRAISE: Assessment of Pain and Posterior Synechiae Reduction With Atropine, an Investigation of Post-Surgical Eyes". The study will evaluate whether atropine eyedrops are beneficial when used after certain eye surgeries.
What is the current status of trial NCT07434635?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 62 participants. The study started on 2026-02. Estimated completion is 2029-02.
What conditions does trial NCT07434635 study?
This clinical trial studies the following conditions: Eye Disorders.
What interventions are being tested in trial NCT07434635?
The interventions under investigation include: Atropine 1% (DRUG).
Who is sponsoring clinical trial NCT07434635?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07434635 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.